Do clinical psychologists have a role in clients’ use of psychotropic medication? A mixed methods investigation exploring current forms of involvement

Aston, Amy; Smith, Sharron; Boos, Danielle De; Tickle, Anna

doi:10.1111/papt.12281

Cited by 2 publications

(1 citation statement)

References 64 publications

(117 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Far too often, for example, patients are started on very small doses of a selec tive serotonin reuptake inhibitor and never increased into therapeutic range, remaining on such medications for months, if not years. Careful interview and discussion with a patient on such matters can be helpful motivation for a patient to discuss their medications more carefully with their primary care provider or other prescriber (Aston et al, 2021).…”

Section: Common Obstacles In Supervision and Ways Of Overcoming Themmentioning

confidence: 99%

Supervising the delivery of cognitive behavior therapy in medical settings.

Guadagnoli¹,

Washburn²,

Butt³

2022

Training and Supervision in Specialized Cognitive Behavior Therapy: Methods, Settings, and Populations.

View full text Add to dashboard Cite

show abstract

Section: Common Obstacles In Supervision and Ways Of Overcoming Themmentioning

confidence: 99%

Supervising the delivery of cognitive behavior therapy in medical settings.

Guadagnoli¹,

Washburn²,

Butt³

2022

Training and Supervision in Specialized Cognitive Behavior Therapy: Methods, Settings, and Populations.

View full text Add to dashboard Cite

show abstract

What is helpful and unhelpful when people try to withdraw from antipsychotics: An international survey

Read

2024

Psychol Psychother

View full text Add to dashboard Cite

ObjectiveAntipsychotics remain the first‐line treatment for people diagnosed with psychotic disorders despite adverse effects which lead many people to stop their medication. Many stop without the support of the prescriber, who may fear relapse. The objective of this study is to better understand the process of withdrawal from antipsychotics, from the perspective of people taking antipsychotics.DesignOnline survey.MethodsAn international online survey elicited quantitative responses about pre‐withdrawal planning (560) and qualitative responses about what was helpful and unhelpful when withdrawing from antipsychotics (443). Responses came from users of antipsychotics in 29 countries.ResultsForty‐seven per cent did not consult their psychiatrist before discontinuing. Only 40% made preparations, most commonly making a plan, gathering information and informing family. The most frequently reported helpful factors were focussing on the benefits of getting off the drugs (including ending adverse effects and feeling more alive), information about withdrawal symptoms and how to withdraw safely, withdrawing slowly, and support from psychologists, counsellors and psychotherapists. The most common unhelpful factor was the psychiatrist/doctor, largely because of their lack of knowledge, refusal to support the patient's wishes and the threat or use of coercion.ConclusionsEvidence‐based, respectful, collaborative responses to patients' concerns about adverse effects and desires to withdraw would probably reduce relapse rates and improve long‐term outcomes. It would definitely help end pervasive breaching of the principle of informed consent and human rights legislation.

show abstract

Do clinical psychologists have a role in clients’ use of psychotropic medication? A mixed methods investigation exploring current forms of involvement

Abstract: Best practices: a program to support shared decision making in an outpatient psychiatric medication clinic.

Cited by 2 publications

References 64 publications

Supervising the delivery of cognitive behavior therapy in medical settings.

Supervising the delivery of cognitive behavior therapy in medical settings.

What is helpful and unhelpful when people try to withdraw from antipsychotics: An international survey

Contact Info

Product

Resources

About